Reporting, revenue for common in-house lab tests dipped in 2020
The fallout from COVID-19 didn’t stop at procedures and services. In 2020, practices reported fewer low-complexity, high-volume lab tests, resulting in a loss of more than $30 million, according to Part B News analysis of Medicare Part B claims data for 2019 and 2020.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.